NCT00890734View on ClinicalTrials.gov

CYT003-QbG10 for Treatment of Allergic Asthma Bronchial

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

November 30, 2010

Conditions
Allergic Bronchial Asthma
Interventions
DRUG

CYT003-QbG10

subcutaneous injection

DRUG

Placebo

subcutaneous injection

Trial Locations (1)

Unknown

Cytos Investigator Sites, Luebeck, Berlin, Wiesbaden, Rodgau, Eisenach

Sponsors
All Listed Sponsors
lead

Cytos Biotechnology AG

INDUSTRY